Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial.

BACKGROUND: We evaluated dolutegravir pharmacokinetics in infants with human immunodeficiency virus (HIV) receiving dolutegravir twice daily (BID) with rifampicin-based tuberculosis (TB) treatment compared with once daily (OD) without rifampicin. METHODS: Infants with HIV aged 1-12 months, weighing ≥3 kg, and receiving dolutegravir BID with rifampicin or OD without rifampicin were eligible. Six blood samples were taken over 12 (BID) or 24 hours (OD). Dolutegravir pharmacokinetic parameters, HIV viral load (VL) data, and adverse events (AEs) were reported. RESULTS: Twenty-seven of 30 enrolled infants had evaluable pharmacokinetic curves. The median (interquartile range) age was 7.1 months (6.1-9.9), weight was 6.3 kg (5.6-7.2), 21 (78%) received rifampicin, and 11 (41%) were female. Geometric mean ratios comparing dolutegravir BID with rifampicin versus OD without rifampicin were area under curve (AUC)0-24h 0.91 (95% confidence interval, .59-1.42), Ctrough 0.95 (0.57-1.59), Cmax 0.87 (0.57-1.33). One infant (5%) receiving rifampicin versus none without rifampicin had dolutegravir Ctrough <0.32 mg/L, and none had Ctrough <0.064 mg/L. The dolutegravir metabolic ratio (dolutegravir-glucuronide AUC/dolutegravir AUC) was 2.3-fold higher in combination with rifampicin versus without rifampicin. Five of 82 reported AEs were possibly related to rifampicin or dolutegravir and resolved without treatment discontinuation. Upon TB treatment completion, HIV viral load was <1000 copies/mL in 76% and 100% of infants and undetectable in 35% and 20% of infants with and without rifampicin, respectively. CONCLUSIONS: Dolutegravir BID in infants receiving rifampicin resulted in adequate dolutegravir exposure, supporting this treatment approach for infants with HIV-TB coinfection.

First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia.

Optimal antituberculosis therapy is essential for favorable clinical outcomes. Peak plasma concentrations of first-line antituberculosis drugs in infants with living HIV receiving WHO-recommended dosing were low compared with reference values for adults, supporting studies on increased doses of first-line TB drugs in infants.

Testing the performance, adequacy, and applicability of an artificial intelligence model for pediatric pneumonia diagnosis.

BACKGROUND: Community-acquired Pneumonia (CAP) is a common childhood infectious disease. Deep learning models show promise in X-ray interpretation and diagnosis, but their validation should be extended due to limitations in the current validation workflow. To extend the standard validation workflow we propose doing a pilot test with the next characteristics. First, the assumption of perfect ground truth (100% sensitive and specific) is unrealistic, as high intra and inter-observer variability have been reported. To address this, we propose using Bayesian latent class models (BLCA) to estimate accuracy during the pilot. Additionally, assessing only the performance of a model without considering its applicability and acceptance by physicians is insufficient if we hope to integrate AI systems into day-to-day clinical practice. Therefore, we propose employing explainable artificial intelligence (XAI) methods during the pilot test to involve physicians and evaluate how well a Deep Learning model is accepted and how helpful it is for routine decisions as well as analyze its limitations by assessing the etiology. This study aims to apply the proposed pilot to test a deep Convolutional Neural Network (CNN)-based model for identifying consolidation in pediatric chest-X-ray (CXR) images already validated using the standard workflow. METHODS: For the standard validation workflow, a total of 5856 public CXRs and 950 private CXRs were used to train and validate the performance of the CNN model. The performance of the model was estimated assuming a perfect ground truth. For the pilot test proposed in this article, a total of 190 pediatric chest-X-ray (CXRs) images were used to test the CNN model support decision tool (SDT). The performance of the model on the pilot test was estimated using extensions of the two-test Bayesian Latent-Class model (BLCA). The sensitivity, specificity, and accuracy of the model were also assessed. The clinical characteristics of the patients were compared according to the model performance. The adequacy and applicability of the SDT was tested using XAI techniques. The adequacy of the SDT was assessed by asking two senior physicians the agreement rate with the SDT. The applicability was tested by asking three medical residents before and after using the SDT and the agreement between experts was calculated using the kappa index. RESULTS: The CRXs of the pilot test were labeled by the panel of experts into consolidation (124/176, 70.4%) and no-consolidation/other infiltrates (52/176, 29.5%). A total of 31/176 (17.6%) discrepancies were found between the model and the panel of experts with a kappa index of 0.6. The sensitivity and specificity reached a median of 90.9 (95% Credible Interval (CrI), 81.2-99.9) and 77.7 (95% CrI, 63.3-98.1), respectively. The senior physicians reported a high agreement rate (70%) with the system in identifying logical consolidation patterns. The three medical residents reached a higher agreement using SDT than alone with experts (0.66±0.1 vs. 0.75±0.2). CONCLUSIONS: Through the pilot test, we have successfully verified that the deep learning model was underestimated when a perfect ground truth was considered. Furthermore, by conducting adequacy and applicability tests, we can ensure that the model is able to identify logical patterns within the CXRs and that augmenting clinicians with automated preliminary read assistants could accelerate their workflows and enhance accuracy in identifying consolidation in pediatric CXR images.

Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change.

BACKGROUND: Although super-boosted lopinavir/ritonavir (LPV/r; ratio 4:4 instead of 4:1) is recommended for infants living with HIV and receiving concomitant rifampicin, in clinical practice, many different LPV/r dosing strategies are applied due to poor availability of pediatric separate ritonavir formulations needed to superboost. We evaluated LPV pharmacokinetics in infants with HIV receiving LPV/r dosed according to local guidelines in various sub-Saharan African countries with or without rifampicin-based tuberculosis (TB) treatment. METHODS: This was a 2-arm pharmacokinetic substudy nested within the EMPIRICAL trial (#NCT03915366). Infants aged 1-12 months recruited into the main study were administered LPV/r according to local guidelines and drug availability either with or without rifampicin-based TB treatment; during rifampicin cotreatment, they received double-dosed (ratio 8:2) or semisuperboosted LPV/r (adding a ritonavir 100 mg crushed tablet to the evening LPV/r dose). Six blood samples were taken over 12 hours after intake of LPV/r. RESULTS: In total, 14/16 included infants had evaluable pharmacokinetic curves; 9/14 had rifampicin cotreatment (5 received double-dosed and 4 semisuperboosted LPV/r). The median (IQR) age was 6.4 months (5.4-9.8), weight 6.0 kg (5.2-6.8), and 10/14 were male. Of those receiving rifampicin, 6/9 infants (67%) had LPV Ctrough <1.0 mg/L compared with 1/5 (20%) in the control arm. LPV apparent oral clearance was 3.3-fold higher for infants receiving rifampicin. CONCLUSION: Double-dosed or semisuperboosted LPV/r for infants aged 1-12 months receiving rifampicin resulted in substantial proportions of subtherapeutic LPV levels. There is an urgent need for data on alternative antiretroviral regimens in infants with HIV/TB coinfection, including twice-daily dolutegravir.

Oral saliva swab reverse transcription PCR for Covid-19 in the paediatric population.

OBJECTIVES: To evaluate the performance of oral saliva swab (OSS) reverse transcription PCR (RT-PCR) compared with RT-PCR and antigen rapid diagnostic test (Ag-RDT) on nasopharyngeal swabs (NPS) for SARS-CoV-2 in children. DESIGN: Cross-sectional multicentre diagnostic study. SETTING: Study nested in a prospective, observational cohort (EPICO-AEP) performed between February and March 2021 including 10 hospitals in Spain. PATIENTS: Children from 0 to 18 years with symptoms compatible with Covid-19 of ≤5 days of duration were included. Two NPS samples (Ag-RDT and RT-PCR) and one OSS sample for RT-PCR were collected. MAIN OUTCOME: Performance of Ag-RDT and RT-PCR on NPS and RT-PCR on OSS sample for SARS-CoV-2. RESULTS: 1174 children were included, aged 3.8 years (IQR 1.7-9.0); 73/1174 (6.2%) patients tested positive by at least one of the techniques. Sensitivity and specificity of OSS RT-PCR were 72.1% (95% CI 59.7 to 81.9) and 99.6% (95% CI 99 to 99.9), respectively, versus 61.8% (95% CI 49.1 to 73) and 99.9% (95% CI 99.4 to 100) for the Ag-RDT. Kappa index was 0.79 (95% CI 0.72 to 0.88) for OSS RT-PCR and 0.74 (95% CI 0.65 to 0.84) for Ag-RDT versus NPS RT-PCR. CONCLUSIONS: RT-PCR on the OSS sample is an accurate option for SARS-CoV-2 testing in children. A less intrusive technique for younger patients, who usually are tested frequently, might increase the number of patients tested.

Comparison of pneumonia features in children caused by SARS-CoV-2 and other viral respiratory pathogens.

BACKGROUND: Pneumonia is a frequent manifestation of coronavirus disease 2019 (COVID-19) in hospitalized children. METHODS: The study involved 80 hospitals in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spanish Pediatric National Cohort. Participants were children <18 years, hospitalized with SARS-CoV-2 community-acquired pneumonia (CAP). We compared the clinical and radiological characteristics of SARS-CoV-2-associated CAP with CAP due to other viral etiologies from ValsDance (retrospective) cohort. RESULTS: In total, 151 children with SARS-CoV-2-associated CAP and 138 with other viral CAP were included. Main clinical features of SARS-CoV-2-associated CAP were cough, fever, or dyspnea. Lymphopenia was found in 43% patients and 15% required admission to the pediatric intensive care unit (PICU). Chest X-ray revealed condensation (42%) and other infiltrates (58%). Compared with CAP from other viral pathogens, COVID-19 patients were older, with lower C-reactive protein (CRP) levels, less wheezing, and greater need of mechanical ventilation (MV). There were no differences in the use of continuous positive airway pressure (CPAP) or HVF, or PICU admission between groups. CONCLUSION: SARS-CoV-2-associated CAP in children presents differently to other virus-associated CAP: children are older and rarely have wheezing or high CRP levels; they need less oxygen but more CPAP or MV. However, several features overlap and differentiating the etiology may be difficult. The overall prognosis is good.

COVCOG 1: Factors Predicting Physical, Neurological and Cognitive Symptoms in Long COVID in a Community Sample. A First Publication From the COVID and Cognition Study.

Since its first emergence in December 2019, coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has evolved into a global pandemic. Whilst often considered a respiratory disease, a large proportion of COVID-19 patients report neurological symptoms, and there is accumulating evidence for neural damage in some individuals, with recent studies suggesting loss of gray matter in multiple regions, particularly in the left hemisphere. There are a number of mechanisms by which COVID-19 infection may lead to neurological symptoms and structural and functional changes in the brain, and it is reasonable to expect that many of these may translate into cognitive problems. Indeed, cognitive problems are one of the most commonly reported symptoms in those experiencing "Long COVID"-the chronic illness following COVID-19 infection that affects between 10 and 25% of patients. The COVID and Cognition Study is a part cross-sectional, part longitudinal, study documenting and aiming to understand the cognitive problems in Long COVID. In this first paper from the study, we document the characteristics of our sample of 181 individuals who had experienced COVID-19 infection, and 185 who had not. We explore which factors may be predictive of ongoing symptoms and their severity, as well as conducting an in-depth analysis of symptom profiles. Finally, we explore which factors predict the presence and severity of cognitive symptoms, both throughout the ongoing illness and at the time of testing. The main finding from this first analysis is that that severity of initial illness is a significant predictor of the presence and severity of ongoing symptoms, and that some symptoms during the initial illness-particularly limb weakness-may be more common in those that have more severe ongoing symptoms. Symptom profiles can be well described in terms of 5 or 6 factors, reflecting the variety of this highly heterogenous condition experienced by the individual. Specifically, we found that neurological/psychiatric and fatigue/mixed symptoms during the initial illness, and that neurological, gastrointestinal, and cardiopulmonary/fatigue symptoms during the ongoing illness, predicted experience of cognitive symptoms.

COVCOG 2: Cognitive and Memory Deficits in Long COVID: A Second Publication From the COVID and Cognition Study.

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been often characterized as a respiratory disease. However, it is increasingly being understood as an infection that impacts multiple systems, and many patients report neurological symptoms. Indeed, there is accumulating evidence for neural damage in some individuals, with recent studies suggesting loss of gray matter in multiple regions, particularly in the left hemisphere. There are several mechanisms by which the COVID-19 infection may lead to neurological symptoms and structural and functional changes in the brain, and cognitive problems are one of the most commonly reported symptoms in those experiencing Long COVID - the chronic illness following the COVID-19 infection that affects between 10 and 25% of patients. However, there is yet little research testing cognition in Long COVID. The COVID and Cognition Study is a cross-sectional/longitudinal study aiming to understand cognitive problems in Long COVID. The first paper from the study explored the characteristics of our sample of 181 individuals who had experienced the COVID-19 infection, and 185 who had not, and the factors that predicted ongoing symptoms and self-reported cognitive deficits. In this second paper from the study, we assess this sample on tests of memory, language, and executive function. We hypothesize that performance on "objective" cognitive tests will reflect self-reported cognitive symptoms. We further hypothesize that some symptom profiles may be more predictive of cognitive performance than others, perhaps giving some information about the mechanism. We found a consistent pattern of memory deficits in those that had experienced the COVID-19 infection, with deficits increasing with the severity of self-reported ongoing symptoms. Fatigue/Mixed symptoms during the initial illness and ongoing neurological symptoms were predictive of cognitive performance.

Antibiotic Prescribing in Children Hospitalized With COVID-19 and Multisystem Inflammatory Syndrome in Spain: Prevalence, Trends, and Associated Factors.

The SARS-CoV-2 pandemic has caused an increase in antibiotic use in different settings. We describe the antibiotic prescribing prevalence, associated factors and trends, as well as concomitant bacterial infections in children hospitalized with COVID-19 or multisystemic inflammatory syndrome related to SARS-CoV-2 in Spain.

Clinical spectrum of COVID-19 and risk factors associated with severity in Spanish children.

We aimed to identify the spectrum of disease in children with COVID-19, and the risk factors for admission in paediatric intensive care units (PICUs). We conducted a multicentre, prospective study of children with SARS-CoV-2 infection in 76 Spanish hospitals. We included children with COVID-19 or multi-inflammatory syndrome (MIS-C) younger than 18 years old, attended during the first year of the pandemic. We enrolled 1200 children. A total of 666 (55.5%) were hospitalised, and 123 (18.4%) required admission to PICU. Most frequent major clinical syndromes in the cohort were mild syndrome (including upper respiratory tract infection and flu-like syndrome, skin or mucosae problems and asymptomatic), 44.8%; bronchopulmonary syndrome (including pneumonia, bronchitis and asthma flare), 18.5%; fever without a source, 16.2%; MIS-C, 10.6%; and gastrointestinal syndrome, 10%. In hospitalised children, the proportions were 28.5%, 25.7%, 16.5%, 19.1% and 10.2%, respectively. Risk factors associated with PICU admission were age in months (OR: 1.007; 95% CI 1.004 to 1.01), MIS-C (OR: 14.4, 95% CI 8.9 to 23.8), chronic cardiac disease (OR: 4.8, 95% CI 1.8 to 13), asthma or recurrent wheezing (OR: 2.5, 95% CI 1.2 to 5.2) and after excluding MIS-C patients, moderate/severe liver disease (OR: 8.6, 95% CI 1.6 to 47.6). However, asthmatic children were admitted into the PICU due to MIS-C or pneumonia, not due to asthma flare.Conclusion: Hospitalised children with COVID-19 usually present as one of five major clinical phenotypes of decreasing severity. Risk factors for PICU include MIS-C, elevation of inflammation biomarkers, asthma, moderate or severe liver disease and cardiac disease. What is Known: • All studies suggest that children are less susceptible to serious SARS-CoV-2 infection when compared to adults. Most studies describe symptoms at presentation. However, it remains unclear how these symptoms group together into clinically identifiable syndromes and the severity associated with them. What is New: • We have gathered the primary diagnoses into five major syndromes of decreasing severity: MIS-C, bronchopulmonary syndrome, gastrointestinal syndrome, fever without a source and mild syndrome. Classification of the children in one of the syndromes is unique and helps to assess the risk of critical illness and to define the spectrum of the disease instead of just describing symptoms and signs.

Dynamics of Reverse Transcription-Polymerase Chain Reaction and Serologic Test Results in Children with SARS-CoV-2 Infection.

OBJECTIVES: To determine the time to reverse transcription-polymerase chain reaction (RT-PCR) negativity after the first positive RT-PCR test, factors associated with longer time to RT-PCR negativity, proportion of children seroconverting after proven severe acute respiratory syndrome coronavirus 2 infection, and factors associated with the lack of seroconversion. STUDY DESIGN: The Epidemiological Study of Coronavirus in Children of the Spanish Society of Pediatrics is a multicenter study conducted in Spanish children to assess the characteristics of coronavirus disease 2019. In a subset of patients, 3 serial RT-PCR tests on nasopharyngeal swab specimens were performed after the first RT-PCR test, and immunoglobulin G serology for severe acute respiratory syndrome coronavirus 2 antibodies was performed in the acute and follow-up (<14 and ≥14 days after diagnosis) phase. RESULTS: In total, 324 patients were included in the study. The median time to RT-PCR negativity was 17 days (IQR, 8-29 days), and 35% of patients remained positive more than 4 weeks after the first RT-PCR test. The probability of RT-PCR negativity did not differ across groups defined by sex, disease severity, immunosuppressive drugs, or clinical phenotype. Globally, 24% of children failed to seroconvert after infection. Seroconversion was associated with hospitalization, persistence of RT-PCR positivity, and days of fever. CONCLUSIONS: Time to RT-PCR negativity was long, regardless of the severity of symptoms or other patient features. This finding should be considered when interpreting RT-PCR results in a child with symptoms, especially those with mild symptoms. Seroprevalence and postimmunization studies should consider that 11 in 4 infected children fail to seroconvert.

APORTE DE HOJARASCA DEL MANGLE NEGRO (Avicennia germinans L. ) EN EL CARIBE COLOMBIANO / CONTRIBUTION OF BLACK MANGROVE (Avicennia germinans L. ) FALLEN LEAVES IN THE COLOMBIAN CARIBBEAN AREA

A pesar que los manglares son reconocidos a nivel mundial como ecosistemas altamente productivos y ecológicamente importantes, en la actualidad, su extensión se ha reducido significativamente debido a las actividades humanas en las zonas costeras. Por lo tanto, es necesario investigar su dinámica y respuestas bajo el creciente y sostenido impacto del cambio climático y antropogénico. Durante dos estaciones climáticas contrastantes (sequía, lluvia) se estudió la producción de hojarasca del mangle negro Avicennia germinans L. en la bahía El Uno cerca al municipio de Turbo, noroccidente de Colombia (8º N). El aporte de materia orgánica fue separado por estructuras (hojas, ramas, flores y frutos) donde se registró un aporte significativamente mayor de hojas. La biomasa seca total durante ambas estaciones fue de 7,09±9,66 y 5,36±5,67 g m-2día-1. Los valores mínimos y máximos fueron de 0,63-8 y 0,49-3,65 g m-2día-1 durante la estación seca y lluviosa, respectivamente. Se detectaron diferencias significativas entre las estructuras orgánicas pero no entre las estaciones climáticas analizadas. Se discuten algunos impactos naturales y antropogénicos pasados y actuales, que afectan la dinámica de los manglares, al igual que la importancia de la producción de hojarasca para la productividad primaria y secundaria, en zonas altamente perturbadas del Caribe colombiano.

Although mangroves are recognized worldwide as highly productive and ecologically important ecosystems , at present its extent has been significantly reduced due to human activities in coastal areas. Therefore, it is necessary to investigate their dynamics and responses under the growing and sustained climatic and anthropogenic impacts. During two contrasting seasons (drought, rain) the fallen leaves production of the black mangrove Avicennia germinans L. was investigated at El Uno Bay, near Turbo Municipality, North-Western Colombia (8º N). Organic matter input was sorted by structure (leaves, branches, flowers, fruits) with leaves registering the highest significant values. Total dry biomass during both seasons was 7.09±9.66 and 5.36±5.67 g m-2day-1. The lowest and highest organic matter values were 0.63-8 and 0.49-3.65 g m-2day-1 during the dry and rainy season, respectively. Significant differences between organic structures but not between seasons analyzed were detected. Some relevant past and present natural and anthropogenic impacts affecting the mangroves dynamics are discussed, as well as the importance of fallen leaves input to the primary and secondary production in highly disturbed zones of the Colombian Caribbean area.

[Three cases of Yersinia pseudotuberculosis gastrointestinal infection having no apparent epidemiological relationship, caused by identical strains]. / Tres casos de infección gastrointestinal sin aparente relación epidemiológica producidos por la misma cepa de Yersinia pseudotuberculosis.

INTRODUCTION: Gastrointestinal infections caused by Yersinia pseudotuberculosis are uncommon in our country and the epidemiology of the infection is uncertain. METHODS: We describe three cases of Y. pseudotuberculosis gastrointestinal infection, all detected within one month of time. A possible epidemiological relationship among these cases, as well as the microbial characteristics of the isolates, was investigated. RESULTS. No epidemiological relationships were found among the three cases. Nevertheless, all three isolates were identical according to phenotyping and molecular marker studies. CONCLUSION: This report discusses the possible source of infection in these cases, with reference to published data from sporadic cases and outbreaks of infection by this microorganism. We suggest that future studies are needed to know the real incidence of Y. pseudotuberculosis in our country.

Síndrome de Terson: Amaurosis reversible secundaria a la hemorragia subaracnoidea (Presentación de 4 casos) / Terson Syndrome: reversible amaurosis secondary to subarachnoideal hemorrage

La pérdida de visión, como consecuencia de una hemorragia a nivel del vítreo en el curso de una hemorragia subaracnoidea, es conocida como Síndrome de Terson. Si bien las hemorragias del vítreo son afecciones bien conocidas y descritas en la literatura oftalmológica como complicaciones de una hemorragia subaracnoidea, es una afección muy frecuente. La fisiopatología de esta complicación no es clara, habiendose planteado por diferentes autores varias teorías para explicar la aparición de la sangre a nivel del vítreo. Si bien su presencia se sospecha por la clínica, solamente la ecografía ocular confirma su existencia. En general, se plantea que tiene buen pronóstico a largo plazo, ya que la recuperación de la visión es la regla, sea espontáneamente o luego de la vitrectomía. Los autores presentan 4 casos de esta rara complicación

Hemorragias intracraneanas que complican la terapéutica anticoagulante oral con Warfarina / Intracranial hemorrhages that complicate oral anticoagulant therapy with warfarin

Le hemorragia intracraneana es una de las más serias y letales complicaciones que puede tener el uso de anticoagulantes orales. En poblaciones de riesgo como la de los hipertensos, los pacientes añosos y los que tienen antecedentes vasculares encefálicos, son los más susceptibles de presentar la complicación con el uso de los anticoagulantes orales. Una vez establecida la complicación intracraneana, las dificultades de su manejo médico y quirúrgico son importantes. La mortalidad de la hemorragia intracraneana secundaria al uso de esta medicación es elevada, pues llega a casi el 65 por ciento. En un período de dos años, los autores asistieron 17 pacientes que presentaron hemorragias intracraneanas: subdurales y parenquimatosas, en tomadores de Warfarina Sódica. Se hace un análisis del manejo de aquellos y del pronóstico final

Hemorragias subaracnoideas grado IV. Mejoría del pronóstico con la cirugía en agudo de los aneurismas intracraneanos / Grade IV subarachnoid hemorrhage, improved prognosis with early surgery of intracranial aneurysms

Es controvertible decidir el momento en que se debe intervenir quirúrgicamente a un paciente con una hemorragia subaracnoidea secundaria a un aneurisma intracraneano, más aún cuando se consideran aquellos enfermos con cuadros graves luego de la hemorragia, que son los de pobre grado (grado IV y V de la clasificación de Hunt y Hess). Muchos autores han insistido en los últimos diez años en la necesidad de operar en agudo a aquellos pacientes con hemorragia subaracnoidea de pobre grado. Para basar este aserto han publicado series con mejoría del pronóstico funcional y con descenso de la tasa de mortalidad, en relación a los no intervenidos. Se presenta una serie de ocho pacientes que ingresaron con hemorragias subaracnoideas grado IV y que fueron tratados en forma "agresiva" con cirugía en agudo. Se efectúa un análisis de los resultados, destacándose que 50 por ciento sobrevivieron a ésta

Hemorragias intracraneanas secundarias a terapéutica trombolítica con estreptoquinasa en el infarto agudo de miocardio / Intracranial hemorrhages secondary to thrombolytic therapy with streptokinase in acute myocardial infarction

La trombolisis coronaria con Estreptoquinasa se emplea cada vez más frecuentemente en el tratamiento del Infarto Agudo de Miocardio, pero se puede complicar con hemorragias encefálicas hasta en un 3 por ciento de los casos. Hay una serie de factores que predisponen a su aparición, como ser: la edad avanzada, la hipertensión arterial, el uso previo de anticoagulantes orales, etc. La hemorragia encefálica secundaria al uso de Estreptoquinasa, es de pronóstico sumamente grave, con un porcentaje de mortalidad de aproximadamente el 70 por ciento. Los autores analizan una pequeña serie de 5 pacientes que durante el tratamiento con Estreptoquinasa por Infarto Agudo de Miocardio presentaron hematomas cerebrales y/o de cerebelo. La mortalidad de la serie fue del 60 por ciento. En todos los casos había claros factores predisponentes para la complicación. Tres fueron operados y de ellos, dos fallecieron

A propósito de 500 casos asistidos por traumatismo encefalocraneano leve / Report of 500 cases cared for mild encephalocranial trauma

Se presenta una serie de 500 pacientes asistidos por traumatismo encefalocraniano (TEC) leve y estudiados tomográficamente. Sólo se incluyeron pacientes con un puntaje de 14 o 15 en la escala de Glasgow. Se evidenciaron lesiones intracraneanas en 9 por ciento de los casos y, fueron operados 12 pacientes. Ningún paciente falleció y 498 tuviero buen resultado. Se analizan y comparan series publicadas. Se pudo lograr la detección precoz de lesiones intracraneanas, potencialmente quirúrgicas, en todos los casos. Se logró una ®mortalidad cero¼ en este tipo de pacientes. Todos los pacientes que consultan por TEC, deben ser estudiados con tomografía computada de cráneo en forma urgente

Hemorragia subaracnoidea perimesencefálica sin malformación demostrable de pronóstico favorable / Perimesencephalic subarachnoid hemorrhage without shown malformation of favourable prognosis

La hemorragia subaracnoidea idiopática o sin causa demostrable, representa según las diferentes estadísticas entre un 4 y un 22 por ciento del total. Recientemente, dentro de éstas se ha identificado un cierto número que tiene un patron tomográfico característico, en que la sangre subaracnoidea se encuentra exclusivamente en las cisternas peritronco: son las llamadas hemorragias subaracnoideas centroencefálicas o perimesencefálicas. Se caracterizan además, por tener una evolución favorable y un pronóstico bueno, por lo que también se las conoce como hemorragia subaracnoideas benignas. Los autores lograron reunir en el periodo de un año, 7 pacientes de este tan poco frecuente tipo de hemorragia subaracnoidea, realizandose un análisis de los casos y una revisión de la limitada bibliográfica existente al respecto